Effect of Lymph Node Ratio in Gastric Cancer to Determine Recurrence Rate After Curative Resection

NCT03778710 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 155

Last updated 2019-03-26

No results posted yet for this study

Summary

D2 gastrectomy is standard treatment of early gastric cancer in Japan but in other countries there is still some discord, especially in Europe and North America. Although the quantity of metastasis cancer in lymph node defines survival regardless of which country the patient is treated, the total number of lymph nodes harvested is an important factor to predict accurate staging and/or D2 gastrectomy. Both of the number total lymph nodes and the metastasis lymph node status in gastric cancer are important factors to decide each prognosis. This study evaluated the correlation between total lymph nodes retrieved and metastasis node by lymph node ratio (LNR) status to determine the recurrence rate after curative resection of gastric

Conditions

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Chairat Supsamutchai, MD · Ramathibodi Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-18
Primary Completion
2019-01-30
Completion
2019-02-20

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03778710 on ClinicalTrials.gov